Follow-up results from the phase 3 EMBER-3 study showed that, as a monotherapy, Inluriyo demonstrated a 38% reduction in the ...

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der ...

Galderma’s Nemluvio (nemolizumab) has shown rapid relief of itch, as well as improvement in sleep, in patients with atopic ...

Health equity is an ambitious goal, but the drive to deliver life-changing innovation to all eligible patients is ...

AstraZeneca and Daiichi Sankyo’s Enhertu, in combination with pertuzumab, has been approved by the US FDA to treat adult ...

The industry is now entering the next era by embedding AI directly into the software field teams’ use every day. The step ...

The US FDA has approved the first ever cell-based gene therapy to treat Wiskott-Aldrich syndrome (WAS).

Nektar Therapeutics has announced top-line results from its trial of rezpegaldesleukin to treat severe to very severe ...

Over three quarters of healthcare professionals call for co-created patient materials to drive engagement and trust, ...

When influence outpaces expertise However, the rise of health content on social media has also fuelled the parallel problem ...

Building a trusted data foundation The starting line for any successful AI journey is data readiness and quality. Before ...

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional ...